Senti Biosciences Holdings (SNTI) Change in Cash (2021 - 2025)

Senti Biosciences Holdings' Change in Cash history runs 5 years deep, the most recent figure standing at $4.2 million for Q4 2025.

• In Q4 2025, Change in Cash fell 88.97% year-over-year to $4.2 million; the TTM figure through Dec 2025 stood at -$31.9 million (down 357.68% YoY), while the FY2025 annual figure was -$31.9 million, down 357.68% from the prior year.
• Change in Cash for Q4 2025 stood at $4.2 million, up from -$9.3 million in the prior quarter.
• The five-year high for Change in Cash was $101.7 million in Q2 2022, with the low at -$57.2 million in Q4 2022.
• The 5-year median for Change in Cash is -$6.4 million (2023), against an average of -$1.9 million.
• Peak annual rise in Change in Cash reached 9167.98% in 2022, while the deepest fall reached 6537.26% in 2022.
• Senti Biosciences Holdings' Change in Cash stood at $889323.0 in 2021, then plunged by 6537.26% to -$57.2 million in 2022, then surged by 88.86% to -$6.4 million in 2023, then jumped by 692.08% to $37.8 million in 2024, then slumped by 88.97% to $4.2 million in 2025.
• Business Quant data shows SNTI's Change in Cash at $4.2 million in Q4 2025, -$9.3 million in Q3 2025, and -$12.2 million in Q2 2025.